Expectations and Side Effects of Endocrine Therapy in Women With Breast Cancer
NCT02088710 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 138
Last updated 2017-09-26
Summary
The purpose of this study is to evaluate the role of patients' response expectations for nocebo side effects, quality of life and adherence during adjuvant endocrine treatment (AET). Furthermore, this study analyses the effects of a structured treatment information on patients' satisfaction with information, response expectations, knowledge and adherence.
Conditions
- Female Breast Cancer
Interventions
- BEHAVIORAL
-
Enhanced information about endocrine therapy
Enhanced information about endocrine therapy, extending clinical routine information
Sponsors & Collaborators
-
Philipps University Marburg
lead OTHER
Principal Investigators
-
Yvonne Nestoriuc, Prof. Dr. · Universitätsklinikum Hamburg-Eppendorf
-
Winfried Rief, Prof. Dr. · Philipps University Marburg
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-01-31
- Primary Completion
- 2012-12-31
- Completion
- 2020-02-29
Countries
- Germany
Study Locations
More Related Trials
-
Impact of Web Application Support Versus Standard Management on Compliance With Adjuvant Hormone Therapy at 18 Months in Patients Treated for Breast Cancer
NCT04554927 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Impact of Obesity on the Efficacy of Endocrine Therapy With Aromatase Inhibitors
NCT01758146 ·Status: UNKNOWN ·Phase: PHASE3
-
Pre-Operative Window of Adjuvant Endocrine Therapy to Inform RT Decisions in Older Women With Early-Stage Breast Cancer
NCT04272801 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Therapeutic Education Intervention in Breast Cancer: PEPs Hormonotherapy
NCT02300675 ·Status: COMPLETED ·Phase: NA
-
An Innovative Smartphone Application for Adverse Event Management During Breast Cancer Adjuvant Chemotherapy
NCT05258461 ·Status: UNKNOWN ·Phase: NA
-
Interactive Care Plan for the Monitoring of Symptoms and Recovery in Patients With Stage 0-III Breast Cancer
NCT04693338 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy of Statin Addition to Neoadjuvant Chemotherapy Protocols for Breast Cancer
NCT04705909 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Patients' Preferences for Adjuvant Endocrine Therapy in Early Breast Cancer
NCT03939156 ·Status: UNKNOWN
-
A Study of Nonsteroidal Aromatase Inhibitors Plus Abemaciclib (LY2835219) in Postmenopausal Women With Breast Cancer
NCT02246621 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
A Text-based Intervention in Improving Adherence to Hormone Therapy in Patients With Stage I-III Hormone Receptor Positive Breast Cancer
NCT04086875 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Effectiveness of Combination of Arimidex and Nolvadex in Adjuvant Therapy of Breast Carcinoma in Postmenopausal Women.
NCT00287534 ·Status: COMPLETED ·Phase: PHASE2
-
Digital Patient Support Program for Self-efficacy and Medication Adherence in Women on Adjuvant Endocrine Treatment for Breast Cancer
NCT06989450 ·Status: RECRUITING ·Phase: NA
-
Neoadjuvant Hormonal Therapy Compared to Neoadjuvant Chemotherapy in Stage IIIB/C and IV Breast Cancer Patients
NCT02995772 ·Status: COMPLETED ·Phase: PHASE3
-
Hormone Therapy in Treating Postmenopausal Women With Receptor-Positive Breast Cancer
NCT00002646 ·Status: COMPLETED ·Phase: PHASE3
-
Letrozole in Preventing Breast Cancer in Postmenopausal Women Who Are at Increased Risk for Breast Cancer Due to High Breast Density
NCT00238316 ·Status: COMPLETED ·Phase: PHASE2
-
Culturally Aware AET Non-Initiation Intervention
NCT05465408 ·Status: COMPLETED ·Phase: NA
-
Clinical Study of Adjuvant Therapy on Post-menopausal Women With Breast Cancer Under the Guidance of the Results of Preoperative Endocrinotherapy
NCT01613560 ·Status: UNKNOWN ·Phase: PHASE2
-
Assessing Women's Attitudes About the Risk of Infertility Related to Adjuvant Therapy for Early Breast Cancer
NCT00062400 ·Status: COMPLETED ·Phase: NA
-
Quality of Life in Postmenopausal Women Who Are Receiving Either Exemestane or Anastrozole With or Without Celecoxib for Stage I, Stage II, or Stage IIIA Primary Breast Cancer
NCT00090974 ·Status: COMPLETED
-
Breast Cancer & Antiestrogenic Therapy & Brain
NCT06346457 ·Status: NOT_YET_RECRUITING
-
Prevalence and Risk Factors for Pain and Related Adverse Reactions Among Breast Cancer Survivors on Aromatase Inhibitors
NCT05628077 ·Status: UNKNOWN
-
Evaluation of Sexual Quality of Life for Breast Cancer
NCT04200001 ·Status: COMPLETED
-
Randomized Study Comparing Pre- and Postoperative vs. Conventional Adjuvant Treatment in Receptor-negative Patients
NCT00309569 ·Status: COMPLETED ·Phase: PHASE3
-
Small-group, Virtual Program for Improving Symptoms and Distress Related to Hormonal Therapy for Breast Cancer Survivors
NCT03837496 ·Status: COMPLETED ·Phase: NA
-
Pilot Study of a an App to Improve Medication Adherence in Breast Cancer Survivors Receiving AIs
NCT04170920 ·Status: COMPLETED ·Phase: NA